Contact Person
    Helen Pettersson

    Senior Project Manager
    Email: hp@mva.org
    Phone: (M) +45 2337 0040
    LinkedIn

    MVA R&D Network meeting

    Welcome to Medicon Valley Alliance R&D Network and our 3rd meeting!

    What can R&D learn from orphan drug development:
    – The use of AI to find the right patients
    – Working closely with stakeholders

    Finding the right treatment for the right patient is one major challenge within R&D. The challenges inherent in drug development in rare diseases has enforced stakeholders in this field in pioneering new ways during their R&D.

    Medicon Valley Alliance, together with one of our members – Zealand Pharma – now welcomes you to the MVA R&D Network and our 3rd meeting where we will discuss lessons learned from drug development in rare diseases and how this could be applied to all drug development. Aspects like how to implement AI and how to relate to and interact with the ever-changing stakeholder landscape will be highlighted.

    Date: 6 May, 2019
    Time: 17:00 – 20:00
    Host: Zealand Pharma A/S
    Venue: Medicon Valley Alliance, Auditorium, Arne Jacobsens Alle 15 , 2300 Ørestad City, Copenhagen
    Cost: Free of charge for MVA members

    Sign up

    The network
    Medicon Valley Alliance R&D Network – an interdisciplinary network for C-level R&D executives (CSOs, CMOs, VPs), university professors and PIs, and top-level managers in the hospital sector. The objective of the network is to strengthen collaboration and knowledge-sharing to stimulate that great science turns into successful innovations for the benefit of patients and society. The network is scheduled to meet twice a year.
    The network is free of charge and is limited to Medicon Valley Alliance members. Non-member organizations and companies are welcome to attend one network event to evaluate whether joining the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically make you able to join the Medicon Valley Alliance R&D Network.

    Program
    More information to come soon

    17.00 – 17.30 Registration, networking and a bite to eat
    17.30 – 17.40 Welcome 
    Petter Hartman, CEO, Medicon Valley Alliance
    Camilla Westergaard Borgen, Commercial Development Director, Zealand Pharma A/S
    17.40-18.25 The use of AI to find the right patients
    17.40 Deploying predictive analytics for precision patient and provider finding

    Oodaye Shukla, Chief Data & Analytics Officer, HVH Precision Analytics, Pennsylvania, US
    18.10 AI at Lund University – ongoing activities and opportunities for academia-industry interaction

    Sonja Aits, Associate Senior Lecturer, Cell Death and Lysosomes Group, Dept. of Experimental Medical Science, Lund University
    18.25-19.25 Working closely with stakeholders
    18.25 Early engagement with regulators to improve drug development

    Steffen Thirstrup, Director, NDA Regulatory Advisory Board, former CHMP member and Division Head at the Danish Medicines Agency
    18.45  Why involve patients in medical research? 

    Jeanette Andersen, EUPATI Patient Expert & Chair, Lupus Europe
    19.05 Panel discussion
    Steffen Thirstrup, Director, NDA Regulatory Advisory Board, former CHMP member and Division Head at the Danish Medicines Agency
    Jeanette Andersen, EUPATI Patient Expert & Chair,Lupus Europe
    19.25-19.30 Concluding remarks
    Camilla Westergaard Borgen, Commercial Development Director Zealand Pharma A/S
    19.30 – 20.00 Networking & refreshments

    For more information please contact Senior Project Manager Helen Pettersson: hp@mva.org

     

    Host Sponsors
     

     

    MVA R&D Network is managed by In collaboration with